Showing 951-960 of 1645 results for "".
Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/programs/cme/incorporating-fcrn-inhibitors-into-clinical-practice-in-chronic-inflammatory-demyelinating-polyneuropathy/27135/Tune in to learn more about how to incorporate FcRn inhibitors into clinical practice for inflammatory demyelinating polyneuropathy (CIDP).Multiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Case Report: Cerebral Aneurysm Rerupture
https://practicalneurology.com/diseases-diagnoses/stroke/case-report-cerebral-aneurysm-rerupture/31817/Antifibrinolytic therapy may induce cerebral aneurysmal thrombosis that can obscure unstable aneurysms, delaying diagnosis and treatment.Headache Disorders: Lifestyle & Behavioral Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-disorders-lifestyle-behavioral-management/31771/Nonmedication treatment may address triggers and symptoms of headache disorders.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Pediatric Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/pediatric-traumatic-brain-injury/31985/Assessment, acute care treatment, and rehabilitation and recoveryGenomics to Gene Therapy in Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/genomics-to-gene-therapy-in-neurology/31565/Recent advances in neurogenomics are changing how we practice neurology.Multiple Sclerosis in the Hispanic/Latinx Population
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-hispaniclatinx-population/31757/Hispanic/Latinx individuals with MS are a diverse group for whom genetic and environmental factors affect prevalence, disease course, and treatment that varies by region.Multiple Sclerosis Treatment in Racial and Ethnic Minorities
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-treatment-in-racial-and-ethnic-minorities/31634/Systematic literature review shows little evidence to guide treatment.